Zurcher Kantonalbank (Zurich Cantonalbank) Compass Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 07, 2023	BUY	$2.64 - $3.48 $64,188 - $84,612	24,314 New	24,314 $77,000

Others Institutions Holding CMPX

# of Institutions

Shares Held

92.4M

Call Options Held

Put Options Held

Orbimed Advisors LLC San Diego, CA

22.4M
Shares

$70.7 Million
0.97% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

11.1M
Shares

$35.2 Million
0.04% of portfolio
Blackstone Inc New York, NY

10M
Shares

$31.7 Million
0.09% of portfolio
Black Rock Inc. New York, NY

6.61M
Shares

$20.9 Million
0.0% of portfolio
Bio Impact Capital LLC Cambridge, MA

5.64M
Shares

$17.8 Million
1.62% of portfolio

View Full List

About Compass Therapeutics, Inc.

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $320M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

More about CMPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account